Mostrar o rexistro simple do ítem

Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

dc.contributor.authorCasal Rubio, Joaquín 
dc.date.accessioned2017-06-07T07:24:58Z
dc.date.available2017-06-07T07:24:58Z
dc.date.issued2015
dc.identifier.issn1699-048
dc.identifier.urihttp://hdl.handle.net/20.500.11940/6172
dc.language.isoeng
dc.titleFinal results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
dc.typeArtigoes
dc.authorsophosSalvador, J
dc.authorsophosManso, L
dc.authorsophosHaba, J. de la
dc.authorsophosJaen, A
dc.authorsophosCiruelos, E
dc.authorsophosVillena, M. C. de
dc.authorsophosGil, M
dc.authorsophosMurias, A
dc.authorsophosGalan, A
dc.authorsophosJara, C
dc.authorsophosBayo, J
dc.authorsophosBaena, J. M
dc.authorsophosCasal, J
dc.authorsophosMel, J. R
dc.authorsophosBlancas, I
dc.authorsophosSanchez Rvira, P.
dc.identifier.doi10.1007/s12094-014-1210-x.
dc.identifier.isi349307800010
dc.identifier.pmid25119930
dc.identifier.sophos19950
dc.issue.number2
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Vigo - Complexo Hospitalario Universitario de Vigo::Oncoloxía médica
dc.page.final326
dc.rights.accessRightsopenAccess
dc.typesophosArtículo Original
dc.volume.number17


Ficheiros no ítem

FicheirosTamañoFormatoVer

Non hai ficheiros asociados a este ítem.

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem